Rochelle Sadeghi, PhD
About Rochelle Sadeghi, PhD
Rochelle Sadeghi, PhD, is the Director of Worldwide Commercial Oncology for Opdivo & Yervoy Lung and H&N Cancers at Bristol Myers Squibb, with extensive experience in oncology strategy and healthcare consulting.
Current Role at Bristol Myers Squibb
Rochelle Sadeghi currently serves as the Director of Worldwide Commercial Oncology, Opdivo & Yervoy Lung and H&N Cancers at Bristol Myers Squibb. In this role, she leads the commercial strategy for the oncology medications Opdivo and Yervoy, specifically targeting lung and head & neck cancers. Her responsibilities include overseeing marketing initiatives, strategic planning, and coordinating with various departments to ensure the successful rollout and uptake of these treatments in the market.
Previous Roles at Bristol Myers Squibb
Before her current position, Rochelle Sadeghi held several roles at Bristol Myers Squibb. She was Director of Worldwide Commercial Oncology Strategy from 2021 to 2022 and prior to that, she served as Associate Director of the same department. Her experience also includes early work as Chair of Academic Affairs for Penn Graduate Women in Science and Engineering from 2015 to 2017 and conducting Ph.D. research in Cell and Molecular Biology - Cancer Biology from 2014 to 2018 in the Laboratory of Dr. Eric S. Witze.
Consulting Experience at Boston Consulting Group
Rochelle Sadeghi worked as a Consultant at Boston Consulting Group (BCG) in Philadelphia, PA, from 2018 to 2020. During her tenure at BCG, she focused on healthcare and life sciences projects. Her role involved providing strategic consulting services to clients, analyzing complex data, and developing recommendations to optimize business operations in the healthcare sector.
Education and Research Background
Rochelle Sadeghi earned her Ph.D. in Cell and Molecular Biology - Cancer Biology from the University of Pennsylvania, where she conducted research in the Laboratory of Dr. Eric S. Witze from 2014 to 2018. She holds a Bachelor's Degree in Molecular Biology and Microbiology from the University of Central Florida, where she also completed undergraduate research in the laboratories of Dr. Karl X. Chai and Dr. Stephen J. King. Additionally, she interned in Cancer Biology Research at the University of Pennsylvania in the Laboratory of Dr. Ben Stanger.
Leadership and Advocacy in STEM
Rochelle Sadeghi has demonstrated significant leadership and advocacy in promoting diversity in STEM fields. She co-founded and served as Vice President of the SACNAS chapter at the University of Central Florida, an organization dedicated to advancing Chicanos/Hispanics and Native Americans in STEM. Additionally, she served as the Chair of Academic Affairs for Penn Graduate Women in Science and Engineering, where she promoted academic and professional development opportunities for women in STEM.